BACKGROUND
Kidney living donation is not a risk-free procedure. Information about the process, risks of nephrectomy, and psychological impact should be given to every candidate, but this practice is not standardized.
OBJECTIVE
We aimed to evaluate the utility of new interactive health technology as a new tool to improving the informed consent process in kidney living donation.
METHODS
This cross-sectional survey study involves all living kidney donor candidates (LD) from Helsinki University Hospital (N=127) from Jan 2019 to Jan 2022. All candidates were invited to use the open institutional portal Health Village-Kidney hub, and the patient-tailored digital care path (LD-dcp), which includes information about the donation process and facilitates communication between clinicians, transplant coordinators, and patients. Participants’ eHealth literacy was evaluated with the eHEALS query, usability with the system usability score (SUS), and system utility was assessed with three 5-point Likert scale surveys. Demographics and socioeconomic data were included. An open-ended question was examined with qualitative content analysis.
RESULTS
The Kidney hub was accessed on average by 8000 visitors monthly mostly from a smartphone (60%), 71 % were females, and 25% were aged over 65. Seven out of 127 LD candidates did not use the LD-dcp. Users´ age ranged from 20 to 79 years. Over 3500 messages were exchanged. Fifty-eight percent of all kidney donor candidates consented to participate in the survey. The mean e-HEALS was 3,77. Search on the internet about kidney donation was significantly more common in females than males (84 % vs 55 %, p= 0.038), and was unrelated to education level (0.475), working status (p= 0.325), or income (p= 0.720). The participants’ experience with the LD-dcp technical aspect was good (mean SUS 4.4) and they found it useful, but not critical to decide to donate. The main concerns were about both donor and recipient coping after surgery.
CONCLUSIONS
LD candidate education about the living donation process was successfully achieved with telemedicine. The LD-dcp is a valuable complementary eHealth tool for clinicians, allowing standardization of steps towards the informed consent process.
CLINICALTRIAL
NCT04791670
INTERNATIONAL REGISTERED REPORT
RR2-doi:10.1136/bmjopen-2021-051166